Josh Hartsel, Ph.D.
Chief Science Officer
Dr. Joshua Hartsel has pioneered large scale extraction techniques for many leading companies in the space (Privateer Holdings, CV Sciences, Ananda Hemp, and Speakeasy) for the past decade. Branching out as the CEO and Co-founder of Delta-9 Technologies and Blue Sky Processing has been a rich and rewarding exercise developing entrepreneurial growth and business development strategies.
“I love building companies, lab and production facilities are only a part of that process” – Dr. Hartsel
As a scientist, first and foremost Dr. Hartsel is a leading authority on cannabis chemistry. As the Director of R&D at CV Sciences, his large-scale extraction expertise earned six High-Times Cannabis Cup awards for concentrates, pioneering the crystallization of CBD. Over his career, he has co-authored several peer-reviewed journals, two book chapters on cannabinoids and terpenes (Nutraceuticals – Efficacy, Safety, and Toxicity as well as Cannabis in Veterinary Medicine), and served as an inventor on key patent applications. One on the isolation of cannabinoids (Improved Process for Generating Hemp Oil with a High Cannabidiol (CBD) Content; US Patent# US9340475 B2) and the other was developing species-selective insecticides for malaria control with funding from the Bill and Melinda Gates Foundation (US Patent# 8,618,162). Dr. Hartsel has extensive experience building large-scale production facilities/analytical chemistry laboratories focused on cannabinoid-based nutritional supplements.